Nevada 2025 2025 Regular Session

Nevada Assembly Bill AB411 Introduced / Bill

                      
  
  	A.B. 411 
 
- 	*AB411* 
 
ASSEMBLY BILL NO. 411–ASSEMBLYMEMBER JAUREGUI 
 
MARCH 12, 2025 
____________ 
 
Referred to Committee on Health and Human Services 
 
SUMMARY—Revises provisions relating to prescription drugs. 
(BDR 54-1100) 
 
FISCAL NOTE: Effect on Local Government: No. 
 Effect on the State: No. 
 
~ 
 
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted. 
 
 
AN ACT relating to prescription drugs; revising provisions relating 
to the labeling of certain prescription drugs under certain 
circumstances; and providing other matters properly 
relating thereto. 
Legislative Counsel’s Digest: 
 Existing law requires the labeling for a prescription drug to include the name of 1 
the prescribing practitioner. (NRS 639.2801) This bill provides that upon request 2 
from the prescribing practitioner, the labeling for a prescription for mifepristone, 3 
misoprostol or their generic alternatives must instead include the name of the 4 
prescribing health care practice instead of the name of the prescribing practitioner. 5 
 
 
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN 
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS: 
 
 Section 1.  NRS 639.2801 is hereby amended to read as 1 
follows: 2 
 639.2801 Unless specified to the contrary in writing on the 3 
prescription by the prescribing practitioner, all prescriptions filled 4 
by any practitioner must be dispensed in a container to which is 5 
affixed a label or other device which clearly shows: 6 
 1.  The date. 7 
 2.  The name, address and prescription serial number of the 8 
practitioner who filled the prescription. 9 
 3.  [The] Except as otherwise provided in this subsection, the 10 
names of the prescribing practitioner and of the person for whom 11 
prescribed. Upon request from the prescribing practitioner, an 12   
 	– 2 – 
 
 
- 	*AB411* 
affixed label or device for a prescription for mifepristone, 1 
misoprostol or their generic alternatives must include the name of 2 
the prescribing health care practice instead of the name of the 3 
prescribing practitioner. 4 
 4.  The number of dosage units. 5 
 5.  The symptom or purpose for which the drug is prescribed, if 6 
included by the practitioner pursuant to NRS 639.2352. 7 
 6.  Specific directions for use given by the prescribing 8 
practitioner. 9 
 7.  The expiration date of the effectiveness of the drug or 10 
medicine dispensed, if that information is included on the original 11 
label of the manufacturer of that drug or medicine. If the expiration 12 
date specified by the manufacturer is not less than 1 year after the 13 
date of dispensing, the practitioner may use a date that is 1 year after 14 
the date of dispensing as the expiration date. 15 
 8.  The proprietary or generic name of the drug or medicine as 16 
written by the prescribing practitioner. 17 
 9.  The strength of the drug or medicine. 18 
 The label must contain the warning: 19 
 20 
 Caution: Do not use with alcohol or nonprescribed drugs 21 
without consulting the prescribing practitioner. 22 
 
H